Loading
BI
Biocartis Stock: price and insider trades · Belgium
No insider purchase over the last 90 days. The latest was filed 10 May 2023.
Biocartis: what insiders have been doing
Only a handful of insider records exist for Biocartis, the last one from 10 May 2023, too few to describe a trend. These figures are compiled from regulatory filings published by FSMA. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 10 May 2023
Declarations1 total
600,000 shares0Options /warrants for employees or managersOff exchangeFSMA:biocartis-0
Canonical exit: 29 Jul 2023 (T+90)
1 of 1 declaration
About Biocartis
Biocartis is a company focused on developing molecular diagnostic solutions. It offers rapid and accurate tests for the diagnosis of diseases, including cancer.
